Literature DB >> 2280190

Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112.

K H Weisgraber1.   

Abstract

Human apolipoprotein (apo) E occurs as three common isoforms (apoE4, E3, and E2), all of which influence plasma cholesterol levels. Although both apoE4 and E3 bind with equal effectiveness to the low density lipoprotein receptor, they associate preferentially with different classes of plasma lipoproteins: apoE4 with very low density lipoproteins, apoE3 with high density lipoproteins. The primary structure of apoE3 differs from that of apoE4 at only a single site; apoE3 has its sole cysteine residue at position 112, while apoE4 contains arginine at position 112 and completely lacks cysteine. The present study investigated how this structural difference between apoE4 and E3 determines their distribution among plasma lipoproteins, and analyzed the role of the disulfide-linked heterodimer apoE-A-II (which apoE4 cannot form) in determining the distribution. Human plasma was incubated with 125I-labeled apoE, and lipoproteins were separated by agarose chromatography. Both apoE3 that had been reduced and alkylated with iodoacetamide and apoE3-A-II distributed with high density lipoproteins, indicating that a combination of an inherent property of the monomeric apoE3 structure and apoE-A-II formation account for distribution of apoE3 to the high density lipoproteins. Cysteamine modification of apoE3 resulted in an apoE4-like distribution, demonstrating that a positive charge at position 112 determined the apoE4 distribution and that the effect was not exclusively due to the presence of arginine at this position.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280190

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  76 in total

1.  Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4.

Authors:  Chiharu Mizuguchi; Mami Hata; Padmaja Dhanasekaran; Margaret Nickel; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2012-07-03       Impact factor: 3.162

2.  ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.

Authors:  Veera Venkata Ratnam Bandaru; Juan Troncoso; David Wheeler; Olga Pletnikova; Jessica Wang; Kathy Conant; Norman J Haughey
Journal:  Neurobiol Aging       Date:  2007-09-20       Impact factor: 4.673

3.  Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis.

Authors:  Qi-Yuan Lin; Jing-Ping Du; Ming-Yi Zhang; Yu-Gwei Yao; Lin Li; Nan-Sheng Cheng; Lu-Nan Yan; Lu-Jia Xiao
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

Review 4.  Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.

Authors:  Jessay Gopuran Devassy; Shan Leng; Melissa Gabbs; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

5.  Cognitive deficits and disruption of neurogenesis in a mouse model of apolipoprotein E4 domain interaction.

Authors:  Samuel O Adeosun; Xu Hou; Baoying Zheng; Craig Stockmeier; Xiaoming Ou; Ian Paul; Thomas Mosley; Karl Weisgraber; Jun Ming Wang
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

6.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Authors:  Sanjeev Sethi; Jeffrey D Gamez; Julie A Vrana; Jason D Theis; H Robert Bergen; Peter F Zipfel; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

7.  Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.

Authors:  Valentin Blanchard; Stéphane Ramin-Mangata; Stéphanie Billon-Crossouard; Audrey Aguesse; Manon Durand; Kevin Chemello; Brice Nativel; Laurent Flet; Maud Chétiveaux; David Jacobi; Jean-Marie Bard; Khadija Ouguerram; Gilles Lambert; Michel Krempf; Mikaël Croyal
Journal:  J Lipid Res       Date:  2018-03-14       Impact factor: 5.922

8.  Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.

Authors:  A M van den Maagdenberg; W Weng; I H de Bruijn; P de Knijff; H Funke; A H Smelt; J A Gevers Leuven; F M van't Hooft; G Assmann; M H Hofker
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

9.  VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.

Authors:  Sarada D Tetali; Madhu S Budamagunta; Catalina Simion; Laura J den Hartigh; Tamás Kálai; Kálmán Hideg; Danny M Hatters; Karl H Weisgraber; John C Voss; John C Rutledge
Journal:  J Lipid Res       Date:  2009-12-03       Impact factor: 5.922

10.  Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms.

Authors:  Takaaki Sakamoto; Masafumi Tanaka; Charulatha Vedhachalam; Margaret Nickel; David Nguyen; Padmaja Dhanasekaran; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2008-01-18       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.